Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupP J Woll, I Judson, S M Lee, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapyA M M Oonk, C van Rijn, M M Smits, et al.
Breast Cancer Research and Treatment|April 17, 2016
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapyL M van Roozendaal, B Goorts, M Klinkert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remissionS Rodenhuis, R de Wit, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft sizeE van der Wall, D J Richel, M J Holtkamp, et al.
Seminars in Oncology|February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer InstituteW W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignanciesA M Westermann, M M Holtkamp, G A Linthorst, et al.
Pageof 19